66 related articles for article (PubMed ID: 10191492)
1. [Aseptic thrombosis of the intracranial venous sinuses in a patient with kidney transplantation and toxic levels of cyclosporine].
Guerrero AL; Arcaya J; Cacho J; Seisdedos L
Med Clin (Barc); 1999 Feb; 112(6):238-9. PubMed ID: 10191492
[No Abstract] [Full Text] [Related]
2. Decreased nephrotoxicity after the use of a microemulsion formulation of cyclosporine A compared to conventional solution.
Ahlmén J; Sundberg A; Gustavsson A; Strömbom U
Transplant Proc; 1995 Dec; 27(6):3432-3. PubMed ID: 8540036
[No Abstract] [Full Text] [Related]
3. Increased cyclosporine blood levels after nisoldipine administration in a renal transplant recipient.
Fourtounas C; Kopelias I; Kiriaki D; Agroyannis B
Transpl Int; 2002 Nov; 15(11):586-8. PubMed ID: 12461666
[No Abstract] [Full Text] [Related]
4. Relationship between MDR1 polymorphism and blood concentration of cyclosporine A.
Wang W; Zhang XD; Guan DL; Lü YP; Ma LL; Hu XP; Zhang P; Wang Y; Chen X
Chin Med J (Engl); 2005 Dec; 118(24):2097-100. PubMed ID: 16438909
[No Abstract] [Full Text] [Related]
5. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T
Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine-associated facial paralysis in a child with renal transplant.
Ozkaya O; Kalman S; Bakkaloğlu S; Buyan N; Söylemezoğlu O
Pediatr Nephrol; 2002 Jul; 17(7):544-6. PubMed ID: 12172772
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
Sharma DR; Singh S
J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
[TBL] [Abstract][Full Text] [Related]
8. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
Ahmadi F; Naseri R; Lessan-Pezeshki M
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
[TBL] [Abstract][Full Text] [Related]
9. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
Kyllönen LE; Salmela KT
Transplantation; 2006 Apr; 81(7):1010-5. PubMed ID: 16612277
[TBL] [Abstract][Full Text] [Related]
10. Elevated blood concentrations of cyclosporine and kidney failure after bezafibrate in renal graft recipient.
Hirai M; Tatuso E; Sakurai M; Ichikawa M; Matsuya F; Saito Y
Ann Pharmacother; 1996; 30(7-8):883-4. PubMed ID: 8826580
[No Abstract] [Full Text] [Related]
11. [Cyclosporine dose monitorization in renal transplantation C2 vs C0].
Marcén R; Villafruela JJ
Nefrologia; 2005; 25(2):106-12. PubMed ID: 15912646
[No Abstract] [Full Text] [Related]
12. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem].
Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B
Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339
[No Abstract] [Full Text] [Related]
13. Persistence of medial hyalinosis of small vessels in an allograft after discontinuation of cyclosporine.
Bastani B; Amin K; Salinas-Madrigal L
Ann Pharmacother; 2004; 38(7-8):1322-3. PubMed ID: 15173553
[No Abstract] [Full Text] [Related]
14. Cyclosporine as a cause of unilateral gynecomastia in renal transplant recipient.
Kumar A; Bansal V; Mehra S; Minz M; Sharma AK
J Assoc Physicians India; 1999 Jul; 47(7):746. PubMed ID: 10778606
[No Abstract] [Full Text] [Related]
15. Cyclosporine lymphocyte maximum level monitoring in de novo kidney transplant patients: a prospective study.
Barbari AG; Masri MA; Stephan AG; El Ghoul B; Rizk S; Mourad N; Kamel GS; Kilani HE; Karam AS
Exp Clin Transplant; 2006 Jun; 4(1):400-5. PubMed ID: 16827634
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
Jankauskiene A; Druskis V; Laurinavicius A
Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
[TBL] [Abstract][Full Text] [Related]
17. [C0 vs C2 levels and their implications in kidney transplantation].
Cuero C; Delgado E; de González M; Medina C; Vernaza A; Moscoso J
Rev Med Panama; 2002; 27():30-3. PubMed ID: 16737196
[TBL] [Abstract][Full Text] [Related]
18. [A new strategy for monitoring levels of cyclosporin A in the blood of patients after kidney transplantation].
Halacová M; Jedlicková B; Průsa R
Ceska Slov Farm; 2003 Nov; 52(6):267-71. PubMed ID: 14661365
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-A induced neurotoxicity after renal transplantation.
Derici U; Arinsoy T; Sindel S; Tali T; Leventoglu A; Sert S
Acta Neurol Belg; 2001 Jun; 101(2):124-7. PubMed ID: 11486560
[TBL] [Abstract][Full Text] [Related]
20. Florid hyperplastic folliculitis on the chin in a male renal transplant patient.
Chua S; Affleck A; Kulkarni K
Clin Exp Dermatol; 2008 Jan; 33(1):98-9. PubMed ID: 18039343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
